Digital PCR (dPCR) and Real-Time PCR (qPCR) Market
Digital PCR (dPCR) and Real-Time PCR (qPCR) Market - Global Industry Assessment & Forecast
Segments Covered
- By Product & Service qPCR Products & Services, qPCR Reagents & Consumables, qPCR Instruments, qPCR Software & Services, dPCR Products & Services, dPCR Instruments, dPCR Reagents & Consumables, dPCR Software & Services
- By Application qPCR Applications, Clinical Applications, Research Applications, Forensic Applications, dPCR Applications
- By End User qPCR End Users, Hospitals & Diagnostic Centers, Research Laboratories & Academic Institutes, Clinical Research Organizations, Pharmaceutical & Biotechnology Companies, Forensic Laboratories
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 5805.67 Million |
Revenue 2030: | USD 11315.90 Million |
Revenue CAGR (2023 - 2030): | 8.70% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | North America |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Sr. No. | Offering | Report Coverage |
1. | Market Size | In terms of Revenue (USD Million) |
2. | Historic Data | 2017 to 2021 |
3. | Forecast Data | 2023 to 2030 |
4. | Market Drivers, Restraints, Opportunities, & Regional Market Trends | Yes |
5. | Market Attractiveness Analysis | Yes |
6. | Segment Analysis | Maximum Segments |
7. | Regional Coverage | 5 Regions |
8. | Country Coverage | Top 22 Countries |
9. | Competitive Landscape and Company Market Share Analysis | Yes. Exhaustive information will be provided in two separate chapters of Competitive Landscape and Company Profiles. |
10. | Porter’s Five Forces Analysis | Yes. |
11. | Value Chain Analysis | Yes |
12. | PEST Analysis | Yes |
13. | Regulatory Landscape | Yes |
14. | Technology Landscape | Yes |
15. | COVID-19 Impact Analysis | Yes. Exhaustive information for Key Strategies Undertaken by Companies, Impact Assessment of the COVID-19 Pandemic by Region, along with Short-term and Long-term dynamics. |
16. | Top startups to watch out for | Yes |
17. | Top 3 Trends to Watch | Yes |
18. | Top 3 Strategies Followed by Major Players | Yes |
19. | Top 3 Predictions by Vantage Market Research | Yes |
20. | Discussion Guide | Yes |
21. | Key Primary Respondents - VERBATIM | Yes |
22. | Transcripts from the Primary Respondents | Additional Cost USD 1,000 |
23. | Others/Miscellaneous |
FAQ
Frequently Asked Question
What is the global demand for Digital PCR (dPCR) and Real-Time PCR (qPCR) in terms of revenue?
-
The global Digital PCR (dPCR) and Real-Time PCR (qPCR) valued at USD 5805.67 Million in 2022 and is expected to reach USD 11315.90 Million in 2030 growing at a CAGR of 8.70%.
Which are the prominent players in the market?
-
The prominent players in the market are Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott Laboratories (US), Agilent Technologies (US), Analytik Jena AG (Germany), Becton, Dickinson and Company (US), bioMérieux SA (France), Danaher Corporation (US), Eppendorf (Germany), Fluidigm Corporation (US), Merck KGaA (Germany), QIAGEN N.V. (German), Takara Bio (Japan), Meridian Bioscience (US), Promega Corporation (US), Enzo Life Sciences, Inc. (US), Bioneer (South Korea), ELITech Group (France), Quidel Corporation (US).
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 8.70% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Digital PCR (dPCR) and Real-Time PCR (qPCR) include
- Growing market penetration in the emerging countries and shifting of consumers' opinions from plant-delivered drugs to genome-based drugs.
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Digital PCR (dPCR) and Real-Time PCR (qPCR) in 2022.